|
PPCS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.16440000000629E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.85749999999896E-05 |
| Normal-vs-Stage2 |
1.717980E-01 |
| Normal-vs-Stage3 |
4.00750000000283E-05 |
| Normal-vs-Stage4 |
4.62100000042653E-07 |
| Stage1-vs-Stage2 |
1.493630E-01 |
| Stage1-vs-Stage3 |
2.976200E-01 |
| Stage1-vs-Stage4 |
1.961820E-02 |
| Stage2-vs-Stage3 |
3.717800E-02 |
| Stage2-vs-Stage4 |
9.136600E-03 |
| Stage3-vs-Stage4 |
2.816600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.00379999995659E-06 |
| Normal-vs-AfricanAmerican |
1.611980E-02 |
| Normal-vs-Asian |
5.192300E-04 |
| Caucasian-vs-AfricanAmerican |
7.082800E-01 |
| Caucasian-vs-Asian |
9.702200E-01 |
| AfricanAmerican-vs-Asian |
7.620600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.982600E-04 |
| Normal-vs-Female |
4.0923000000026E-05 |
| Male-vs-Female |
9.083800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.63021999999291E-05 |
| Normal-vs-Age(41-60Yrs) |
2.242600E-04 |
| Normal-vs-Age(61-80Yrs) |
6.984200E-03 |
| Normal-vs-Age(81-100Yrs) |
5.635800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.029000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.535550E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.381800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.014800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.913000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.604400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.916800E-01 |
| Classical-VS-Follicular |
1.266320E-02 |
| Classical-VS-Other |
8.401800E-01 |
| Classical-VS-Normal |
2.94810000001089E-06 |
| Tall-VS-Follicular |
2.931900E-02 |
| Tall-VS-Other |
9.413200E-01 |
| Tall-VS-Normal |
8.197100E-04 |
| Follicular-VS-Other |
3.531000E-01 |
| Follicular-VS-Normal |
1.366000E-01 |
| Other-VS-Normal |
5.918300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.963130E-03 |
| Normal-vs-N1 |
3.20969999467735E-08 |
| N0-vs-N1 |
6.755000E-04 |
|
|
